EUVIMEDEUVIMED entdecken
Crossref

Hydroxurea treatment in sickle cell children

Marie-Hélène Odièvre, Malika Benkerrou, Marie Belloy, Jacques Elion

Paediatric and Perinatal Drug Therapy · 01.06.2008 · 8 (4) · 158-170

DOI: 10.1185/146300908x292060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Paediatric and Perinatal Drug Therapy, erschienen am 01.06.2008. Verfasst von Marie-Hélène Odièvre und 3 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sickle cell anaemia, the most prevalent genetic disease in the black population, is characterised by the polymerisation of the abnormal haemoglobin S, which leads to vascular occlusion and severe painful crisis. Hydroxyurea is the fi rst drug that has been shown to reduce the clinical severity of sickle cell anaemia in adults. Several trials have been carried out in more than 400 children in the last decade, using different therapeutic schedules. Enrolment was based on clinical vasoocclusive severity and few studies included children with cerebrovascular events. Hydroxyurea enhanced fetal haemoglobin expression in almost all the children, despite a large interindividual variability. Hydroxyurea signifi cantly reduces the number of vasoocclusive crises, hospitalisations, the frequency of the acute chest syndrome and the rate of transfusion. Long-term tolerance to hydroxyurea is good. However, clinical response does not correlate consistently with the degree and with the time of increment in fetal haemoglobin, suggesting that hydroxyurea may mediate some of its clinical benefi ts through other mechanisms such as the reduction of sickle erythrocytes – endothelial cells adherence and of the vasoconstrictive stimulus.

Zitieren

APA

Odièvre, M., Benkerrou, M., Belloy, M., & Elion, J. (2008). Hydroxurea treatment in sickle cell children. Paediatric and Perinatal Drug Therapy, 8(4), 158-170. https://doi.org/10.1185/146300908x292060

Vancouver

Odièvre M, Benkerrou M, Belloy M, Elion J. Hydroxurea treatment in sickle cell children. Paediatric and Perinatal Drug Therapy. 2008;8(4):158-170. doi:10.1185/146300908x292060

BibTeX
@article{Odivre2008,
  author = {Odièvre, Marie-Hélène and Benkerrou, Malika and Belloy, Marie and Elion, Jacques},
  title = {Hydroxurea treatment in sickle cell children},
  journal = {Paediatric and Perinatal Drug Therapy},
  year = {2008},
  volume = {8},
  number = {4},
  pages = {158--170},
  doi = {10.1185/146300908x292060}
}
Kostenlos starten →